Member Info for MisterPositive

Trading4good.

Excellent post. FCA slight delay is just that.

Otherwise why would FCA propose Sandbox testing?

Some here try to twist things to suit their agenda of whether in or out of GST. Why else they here?

Hmmm....LoL

Oriole MCap of £5m is just hilarious.

Chesser Resources (our SENALA neighbour) sitting close to 52 week high around AUD71m MCap (circa £40m) after Fortuna Silver deal.

ORR share of SENALA license alone should be lot more than £5m MCap.

ORR now also got JORC resource at Bibemi licence in Cameroon, which is set to grow further to potentially multi-million Ounce Gold deposit.

Not even fully exploited the Lithium upside that now the company is pursuing i addition to Gold, both in Cameroon.

Time to load up while still cheap. All holders who have accumulated these Golden nuggets should do very well. Just a patience game.

Lithium also in play at MBE licence. Cameroon licences are huge and looking highly prospective from results seen so far. Lot more to come here.

Katstrangler.

Your negative spin is pretty obvious after you sold and now waiting to buy back in.....LoL

Obviously your tone with suddenly change soon as you back in....hilarious !!!

Also waiting for New Acquisition update.

Who they in talks with ?

Artificial Intelligence space ?

Should find out soon.

Been so busy, did not realise this fake drop today.

Excellent Top Up opportunity for tomorrow.

Devote funding on its way. Draw down was to build a cash buffer in my view.

Week has just started. News can drop anytime.

Folks that already sold should be bit worried now incase intra-day RNS pops up and they get caught with their pants down....LoL

NICE Consultation period ends this week 9 June.

Should expect some sort of news release.

Already received initial recommendation from NICE on stroke tests.

Wowzer...that £135k is a whopper !!!

May be someone got a heads up for next week.

Just a waiting game now.

Ah ok. Sorry no NOMAD.

Will wait for NORMAN then to get back in office after 2 weeks off sick and sign off the dammnn thing.....LoL.

FCA news week in my view should trigger a major re-rate here and fast.

Agree. Might have received agreement in principle already so to speak but need to get everything drafted and Nomad to review before releasing RNS

Once Devote funding is in, we will not need Riverfort anymore.

Bit of cash cushion in the interim is good.

Devote funding should be with us soon. Plus R&D tax credits on top.

In the meantime we can always get Collaboration deal with incoming partner injecting big chunk of cash in return for maybe 10-20% Equity stake.

Both AIHL and Stroke tests should gain further traction in coming weeks / months.

Only around 100m shares in issue.

Moves very fast this one as seen how quickly it went from 20p to 48.86p just few months ago.

Even better when this really stormed higher from 20p to 80p in just few days.

With lot of news in the pipeline, this can repeat either of the above 2. Better to get hold of your golden tickets not to miss out.

Can see this heading into 30p bracket next week ahead of news (or newsleak) before that.

Grimshady.

Excellent points in that post. Would make perfect business sense.

GDR genetic tests and its advanced platform could be used by bigger Pharma companies who want both: quick & reliable tests data.

FDA update would be huge as that is a Monster market size.

Added few more. Keeps going to NT for large Qty.

Yes. Heron-1 production should come online this year. They know it will take time to get production to 30k bopd to feed the Oil refinery.

LP cannot be that far off....surely.

TR-1 can be delayed by few days. Activity defo seems to have picked up notch or two. Maybe someone in the know buying in before RNS is released. Better to be in and be comfortable.

Roger. You never know. AIHL tests are first of its kind available exclusively at Genedrive. Add the Stroke tests to that.

News spreading in Medical circles & Social media.

Surely BIG PHARMA or another bigger Bio-Tech company would be aware of what Genedrive has developed.